• OPEN AN ACCOUNT
Indian Indices
Sensex
83,627.69 -250.48
( -0.30%)
Global Indices
Nasdaq
49,609.72 84.64
(0.17%)
Dow Jones
6,998.08 10.80
(0.15%)
Hang Seng
53,586.32 1,646.43
(3.17%)
Nikkei 225
10,138.60 -2.10
(-0.02%)
Forex
USD-INR
90.22 0.30
(0.34%)
EUR-INR
104.95 0.05
(0.04%)
GBP-INR
120.87 0.01
(0.01%)
JPY-INR
0.57 0.00
(-0.40%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
330.3875196
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
35.94
34158.02
EPS(TTM)
Face Value()
Div & Yield %
76.07
2
1.03
 

Hyundai Motor sells 58,702 vehicles in Dec'25; exports rose 26.5% YoY
Jan 02,2026

In the domestic market, the company sold 42,416 vehicles while total exports added up to 16,286 units.

The company stated that it has closed calendar year 2025 with an optimized network stock, ensuring healthy inventory management.

Tarun Garg, managing director & CEO, HMIL said: 'Driven by the positive momentum from GST 2.0 reforms, Hyundai Motor India recorded a robust 6.6% year-on-year growth in total monthly sales for December 2025.

Further, reinforcing our ‘Made-in India, Made-for-the-World’ goal, we delivered 26.5% year-on-year growth in exports volume in December, reaffirming our commitment to offering world-class products manufactured indigenously.'

Hyundai Motor India manufactures and sells passenger cars, along with vehicle parts and accessories.

The company's consolidated net profit rose 14.31% to Rs 1,572.26 crore on a 1.15% increase in revenue to Rs 17,155.83 crore in Q2 FY26 as compared with Q2 FY25.

The scrip fell 2.00% to currently trade at Rs 2264 on the BSE.